Building A Biotech Hub With Intellia Therapeutics' John Leonard, M.D.
55:26
Biotech Story Time With Tal Zaks, M.D. (Part 1)
52:51
A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.
1:04:42
Intellia’s Modular CRISPR/Cas9 Gene Editing Platform for the Treatment of Disease
46:17
Building Biotech to Last [Entire Talk]
51:49
Optimizing Lentiviral Purification: Enhancing Chromatography With Monoliths
12:50
Intellia Therapeutics
1:03:51
Manufacturing Partnership With Life Biosciences Jerry McLaughlin and Forge Biologics' John Maslowski
31:15